FierceBiotech

ICON Acquires Firecrest Clinical

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today ...
Yahoo Finance

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

DUBLIN, December 02, 2025--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges ...
Computer Weekly

How research firm Icon is using analytics and wearables to enhance clinical trials

Contract research firm Icon is preparing to ramp up the use of analytics and wearable technologies to increase the appeal of clinical trials as a care option and to boost efficiency of its operations.
Finanznachrichten

ICON plc: ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites face during study startup.